- Home
- STM vs WAT Comparison
STM vs WAT Comparison
Compare STM & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STM
- WAT
- Stock Information
- Founded
- STM 1987
- WAT 1958
- Country
- STM Netherlands
- WAT United States
- Employees
- STM N/A
- WAT N/A
- Industry
- STM Semiconductors
- WAT Biotechnology: Laboratory Analytical Instruments
- Sector
- STM Technology
- WAT Industrials
- Exchange
- STM Nasdaq
- WAT Nasdaq
- Market Cap
- STM 28.2B
- WAT 17.8B
- IPO Year
- STM 1994
- WAT 1995
- Fundamental
- Price
- STM $25.91
- WAT $295.50
- Analyst Decision
- STM Buy
- WAT Hold
- Analyst Count
- STM 7
- WAT 14
- Target Price
- STM $36.75
- WAT $374.07
- AVG Volume (30 Days)
- STM 6.1M
- WAT 586.5K
- Earning Date
- STM 10-30-2025
- WAT 10-31-2025
- Dividend Yield
- STM 1.18%
- WAT N/A
- EPS Growth
- STM N/A
- WAT 10.77
- EPS
- STM 0.71
- WAT 11.09
- Revenue
- STM $11,855,000,000.00
- WAT $3,046,056,000.00
- Revenue This Year
- STM N/A
- WAT $7.19
- Revenue Next Year
- STM $12.98
- WAT $6.40
- P/E Ratio
- STM $35.64
- WAT $26.65
- Revenue Growth
- STM N/A
- WAT 5.89
- 52 Week Low
- STM $17.25
- WAT $275.05
- 52 Week High
- STM $33.47
- WAT $423.56
- Technical
- Relative Strength Index (RSI)
- STM 44.01
- WAT 47.98
- Support Level
- STM $25.68
- WAT $288.90
- Resistance Level
- STM $27.06
- WAT $303.24
- Average True Range (ATR)
- STM 0.57
- WAT 8.76
- MACD
- STM 0.00
- WAT 0.63
- Stochastic Oscillator
- STM 24.09
- WAT 37.96
About STM STMicroelectronics N.V.
A merger between Italian firm SGS Microelettronica and the nonmilitary business of Thomson Semiconducteurs in France formed STMicroelectronics in 1987. STMicroelectronics is a leader in a variety of semiconductor products, including analog chips, discrete power semiconductors, microcontrollers, and sensors. It is an especially prominent chip supplier to the industrial and automotive industries.
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.